Skip to main content

Find Clinical Trials

Home
Conditions
Biliary Tract Neoplasms

Clinical trial condition

Biliary Tract Neoplasms

Explore clinical trials studying Biliary Tract Neoplasms. Study availability and eligibility vary by location and protocol.

250 public trials 39 recruiting studies

Refine in advanced search Browse all conditions

Biliary Tract Neoplasms trial results

Completed

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

NCT00004074

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +257 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Biological Therapy in Treating Patients With Metastatic Cancer

NCT00004604

Conditions: Adenocarcinoma, Adnexal Diseases, Bile Duct Diseases, +92 more
Locations: Duke Comprehensive Cancer Center Durham, North Carolina, United States

View Trial Details

Completed

Biliary Stenting With or Without Photodynamic Therapy in Treating Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors That Cannot Be Removed by Surgery

NCT00513539

Conditions: Bile Duct Diseases, Bile Duct Neoplasms, Biliary Tract Diseases, +9 more
Locations: Aintree University Hospital Liverpool, England, United Kingdom

University College Hospital London, England, United Kingdom

Queen's Medical Centre Nottingham, England, United Kingdom

Ninewells Hospital Dundee, Scotland, United Kingdom

View Trial Details

Completed

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

NCT00005842

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +135 more
Locations: Brooke Army Medical Center Fort Sam Houston, Texas, United States

Institute for Drug Development San Antonio, Texas, United States

View Trial Details

Completed

Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal Cancer

NCT00003439

Conditions: Adenocarcinoma, Adnexal Diseases, Anus Diseases, +54 more
Locations: University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer

NCT00028496

Conditions: Adenocarcinoma, Adenocarcinoma of the Colon, Adenocarcinoma of the Gallbladder, +96 more
Locations: Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

View Trial Details

Completed

S0514 Sorafenib in Treating Patients With Unresectable or Metastatic Gallbladder Cancer or Cholangiocarcinoma

NCT00238212

Conditions: Adenocarcinoma With Squamous Metaplasia of the Gallbladder, Adenocarcinoma of the Extrahepatic Bile Duct, Adenocarcinoma of the Gallbladder, +17 more
Locations: Southwest Oncology Group San Antonio, Texas, United States

View Trial Details

Completed

Effects of Preoperative Immunonutrition in Patients Undergoing Pancreaticoduodenectomy

NCT01256034

Conditions: Bile Duct Cancer, Bile Duct Diseases, Bile Duct Neoplasms, +11 more
Locations: Chiba University Chiba, Japan

View Trial Details

Completed

Interleukin-12 in Treating Patients With Cancer in the Abdomen

NCT00003046

Conditions: Adenoma, Anal Cancer, Anus Diseases, +44 more
Locations: University of Texas - MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Gemcitabine With or Without Cisplatin in Treating Patients With Unresectable Locally Advanced or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors

NCT00262769

Conditions: Bile Duct Diseases, Bile Duct Neoplasms, Biliary Tract Diseases, +9 more
Locations: Basingstoke and North Hampshire NHS Foundation Trust Basingstoke, England, United Kingdom

Queen Elizabeth Hospital at University Hospital of Birmingham NHS Trust Birmingham, England, United Kingdom

Addenbrooke's Hospital Cambridge, England, United Kingdom

Cumberland Infirmary Carlisle, England, United Kingdom

View all 25 locations

View Trial Details